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The antibody response in experimental ocular
toxoplasmosis
Abstract Background: The dynam-
ics of the humoral immune response
in ocular toxoplasmosis (OT) are
poorly understood. We therefore in-
vestigated this process in a rabbit
model of the disease. Materials and
methods: Of 24 infection-naïve adult
rabbits, 12 were left untreated and 12
were systematically infected with
5,000 tachyzoites of the non-cyst-
forming BK strain of Toxoplasma
gondii. Three months later, all rabbits
were inoculated transvitreally with
5,000 tachyzoites of Toxoplasma
gondii. Paired samples of aqueous
humor and serum were analyzed
temporally for their total and specific
IgG contents. Results: In infection-
naïve rabbits with primary OT, spe-
cific IgG reached detectable levels in
the inoculated eyes between 5 and
15 days after inoculation. In infection-
immunized rabbits with secondary
OT, a significant increase in specific
IgG was regularly detected after
5 days. The antibody ratio C was
diagnostic (≥3) from day 15 onward
in primary OT and from day 21
onward in secondary OT. In the
uninfected partner eyes, the antibody
ratio C was found sporadically diag-
nostic from day 15 onward in primary
OT, but at no time in secondary OT.
Specific IgG persisted both locally
and in the serum until the end of the
monitoring period (100 days).
Conclusion: Our findings relating to
the rabbit model of OT reveal three
features of clinical relevance: a diag-
nostic window precedes the estab-
lishment of a humoral immune
response; specific antibodies persist
long after the cessation of disease
activity; and in primary OT, the
antibody ratio C may also increase in
the uninfected partner eye.
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Introduction
Ocular toxoplasmosis is the most frequent cause of
posterior uveitis [26, 36] and of the associated visual
impairment in immunocompetent individuals [37]. The
diagnosis of this etiology is based upon characteristic
clinical manifestations [5, 37, 48]. However, atypical
clinical pictures also exist, and these are not so readily
identified, even by experienced practitioners [8, 11, 27].
This circumstance raises questions as to the sensitivity and
specificity of the clinical diagnosis, which, in the absence
of a sufficiently sensitive laboratory test for the disease, is
still regarded as the gold standard [45].
Various serological tests have been approved to confirm
a past systemic infection. These are based on the detection
of specific IgG in the serum in the absence or, more rarely,
in the presence of low levels of specific IgM [25, 33].
Consequently, although the absence of specific IgG permits
an exclusion of ocular toxoplasmosis, its presence does not
confirm the existence of the disease.
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In atypical cases, a speedy laboratory confirmation of the
suspected clinical diagnosis is necessary [38], and this may
be achieved in 60–80% of cases by a combined analysis of
the aqueous humor and serum. This is based on the
detection of local production or at least a locally increased
concentration of specific IgG and, more rarely of IgA or
IgM [3, 11, 20, 32, 33]. The sensitivity and the specificity
of this combined aqueous humor and serum analysis have
been established only recently [52]. From a practical point
of view, the crux of the matter in human studies is a correct
clinical diagnosis, which is still deemed to be the gold
standard for clinical laboratory testing. The predictive
value of the clinical diagnosis depends greatly on the
clinician’s experience. But since the sensitivity of the
laboratory tests is still unsatisfactory, the clinical picture
and the course of the disease under therapy may be the only
available pointers for a diagnosis. The strength or weakness
of the clinical diagnosis may contribute to the variable
sensitivity (i.e., confirmation frequency) of the results
gleaned from combined aqueous humor and serum
analyses, which ranges from 50 to 85% [7, 20, 29, 35,
42]. Moreover, the proportion of false-negatives and, worse
still in terms of the treatment consequences, of false-
positives, is as yet unknown.
The difficulty in establishing the predictive power of a
laboratory test in the clinical setting may be exemplified
with the Goldmann–Witmer index, which is the oldest and
probably still the most meaningful laboratory indicator of
ocular toxoplasmosis. Even now, 50 years after the
introduction of this test for uveitis by Goldmann and
Witmer [23], the time dependence of the findings, although
recognized [20], has not been systematically investigated.
A cut-off value for the interpretation of data was set in 1966
on the basis of clinical evidence [10] and has since been
corrected according to experience [28, 29]. But a high
proportion of clinically typical cases still fail to manifest a
sufficiently large local IgG response to permit laboratory
confirmation of the disease. Hence, the inclusion of other
tests, such as the determination of antibody avidity [18, 50,
53], the detection of specific IgA [20], and immunoblotting
[21, 52], has been advocated to improve the diagnostic
yield of the antibody analysis. Finally, qualitative and
quantitative measurements of local antibody production are
frequently inconsistent [21]. Although the synthesis of
oligoclonal IgG is detected in up to 87% of the aqueous
humor samples of ocular toxoplasmosis patients, there is
also evidence of a polyspecific immune response in
unrelated chronic inflammatory diseases, such as multiple
sclerosis [43]. These discrepancies, and our inability to
rationalize them, reflect our poor understanding of the
pathophysiological mechanisms underlying local antibody
production.
The present experimental study was undertaken with a
view to shedding further light on several principal aspects
of local IgG production in ocular toxoplasmosis using a
rabbit model of the disease. We wished to follow the time
course of local specific antibody production, bilaterally, in
naïve and systematically infection-immunized rabbits,
which were subsequently inoculated with tachyzoites of
Toxoplasma gondii in only one eye.
Materials and methods
Animal experiments
All animal experiments were approved by the local and
institutional Animal Ethics Committee, and were per-
formed according to the Principles of laboratory animal
care (NIH publication No. 85–23, revised 1985) and to the
ARVO guidelines for animal research under the surveil-
lance of the local Public Veterinary Health Authorities.
Experimental ocular toxoplasmosis was induced in infec-
tion-naïve rabbits or secondarily induced by intraocular re-
infection in systemically infection-immunized animals as
previously reported [19], using the same strain of Toxo-
plasma gondii tachyzoites.
Twenty-four seronegative rabbits obtained from a local
breeder were used in this study. They were of both sexes,
were at least 4 months old, and had a body weight ranging
from 3.5 to 5 kg. Twelve of the rabbits were left untreated
until the time of ocular infection (group 1). The other 12
rabbits (group 2) were each infected subcutaneously with
5,000 tachyzoites of the virulent, non-cyst-forming BK
strain of Toxoplasma gondii. Between days 8 and 28, they
received intramuscular injections of clindamycin (20 mg/
kg of body weight/day) to prevent a lethal course of events.
A 3-month period was then allowed for the infection to
settle down. At the end of this period, both eyes of all
rabbits (groups 1 and 2) underwent dilated pupil fundo-
scopy in order to exclude any ocular pathology. The left
eye was infected transvitreally with tachyzoites of the BK
strain of Toxoplasma gondii under indirect ophthalmo-
scopic control. The right eye of each rabbit served as an
uninfected control. Between days 8 and 28, all animals
received an intramuscular injection of clindamycin, again
to prevent a lethal course of events. The rabbits were
subjected to regular clinical examination. Blood and
aqueous humor samples from both eyes were collected
under conditions of general anesthesia, prior to infection,
and on days 5, 10, 15, 21, 28, 35, 42, 60, 90, and 100. All
samples were processed immediately as described below,
and then stored at −20°C until required for the antibody
analyses, which were run simultaneously.
Methods
Sample collection and work-up
Aliquots of 150–250 μl of aqueous humor were collected
by anterior chamber puncture using a 30-gauge needle and
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a tuberculin syringe. Each sample was centrifuged
immediately after its collection. The sediment was used
for the amplification of DNA (data not presented here) and
the supernatant for the antibody analysis. Serum was
obtained from a blood sample after clotting and centrifu-
gation. This was likewise used for the antibody analysis.
Total rabbit IgG
Total rabbit IgG was quantified using a customized rabbit
IgG ELISA test system under standard conditions. A
triplicate set of controls with a given antibody concentra-
tion was run in parallel with the test samples on each test
plate to internally equilibrate the system. The test samples
were run in duplicate and the average measurement was
used for subsequent calculations.
Specific rabbit anti-toxoplasma IgG
Specific rabbit anti-toxoplasma IgG was quantified using a
special customized ELISA system, which was developed
for the analysis of a larger number of animal samples than
is possible using commercial test systems. Prior to a
definitive establishment of this test system, we compared
the results yielded with those obtained using a commercial
Toxoplasma IgG ELISA test system (Platelia Toxo; Sanofi-
Diagnostics Pasteur, Marnes la Coquette, France), which
we employed for routine testing. Freshly frozen tachyzoites
from the culture supernatants of infected HEP-2 cell lines
(passages 7–15) were added to the coating buffer (0.1 M
Na2CO3 and 0.1 MNaHCO3 [pH 9.6]) at a concentration of
2.5×104/ml after thorough washing and disruption by
freezing and thawing. All test plates were coated in parallel
and stored in a vacuum at −20°C for less than 6 weeks prior
to the analyses. They were then washed with blocking
reagent (phosphate-buffered saline [pH 7.4; Hospital
Pharmacy, Inselspital Bern, Switzerland] containing 0.1%
Tween and 2% fetal calf serum). Duplicate test samples
were diluted 1:100 in phosphate-buffered saline (pH 7.4)
and then incubated with the test plates for 2 h at 37°C. The
test plates were thoroughly rinsed and then incubated with
alkaline-phosphatase-conjugated goat anti-rabbit IgG and
naphthol AS as a substrate. The plates were scanned with
an ELISA reader (SpectraMax 250; Molecular Devices,
Sunnyvale, CA, USA) to quantify the information. For
calibration purposes, standard rabbit serum containing
specific IgG at concentrations of approximately 6, 60, 240,
and 1,000 WHO unit equivalents (IU) was run in triplicate
on each test plate. The reproducibility of the results was
confirmed by running a randomly selected portion of the
test samples (approximately 10%) on a separate occasion.
The lower and upper cut-off levels for this assay were set at
4 and 4,000 IU respectively.
Whilst setting up this study, we attempted to quantify not
only IgG but also IgM and IgA. Numerous commercially
available products of specific rabbit IgM and IgA were
tested, but none of these were sufficiently specific to permit
their unique determination without binding to rabbit IgG.
The Goldmann–Witmer coefficient (antibody ratio C)
was calculated using Desmonts’ formula ([10]): antibody
ratio C=[specific IgG in the aqueous humor/total IgG in the
aqueous humour]/[specific IgG in the serum/total IgG in
the serum]. An antibody ratio C of more than or equal to 3
was assumed to be indicative of local antibody production.
In the present study, data are described using descriptive
measures such as the median, minimal and maximal values,
and the standard deviation. These are displayed graphically
when appropriate. The levels of total IgG in the aqueous
humor and serum are presented in a single figure. To avoid
cluttering, the minimum and maximum values and the
standard deviations have been omitted.
The main object of this non-comparative study was to
describe temporal changes in antibody concentration.
Hence, for a given set of data, the results obtained at
each time point were statistically compared only with the
base-line value (day 0). For this comparison (Student’s t
test), the data were assumed to be normally distributed. The
level of statistical significance was set at p<0.05.
Results
Although prophylactic measures were taken to prevent a
lethal course of events, 3 of the 12 infection-immunized
rabbits (secondary ocular toxoplasmosis [group 2]) and 2
of the 12 infection-naïve rabbits (primary ocular toxoplas-
mosis [group 1]) died within 14 days of inoculation with
tachyzoites of Toxoplasma gondii.
In all of the remaining animals, retinochoroiditis with
marked vitreal infiltration became apparent 3–5 days after
transvitreal inoculation. Systemic signs of infection, such
as an increased body temperature and inappetence were
manifested from days 5 to 7 onward.
In both the primary ocular toxoplasmosis group (group
1; n=10) and the secondary ocular toxoplasmosis group
(group 2; n=9), a diagnostic window describing the time
elapsing between the onset of clinical symptoms and the
induction of local antibody production was apparent before
the aqueous humor levels of Toxoplasma-specific IgG
began to increase significantly in either the inoculated or
the partner eye (Fig. 1a–d). In group 1 (primary ocular
toxoplasmosis), a statistically significant increase in spe-
cific IgG above the detection threshold began on day 15 in
the infected eye and on day 49 in the uninfected partner eye
(p<0.05), but in single instances, it was detectable from
day 5 onwards. In group 2 (secondary ocular toxoplasmo-
sis), the increase in specific IgG began on day 5 in the
infected eye (p<0.05). In the uninfected partner eye, the
local level of specific IgG did not increase significantly at
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Fig. 1 (continued)
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any point in time (p>0.05). In group 1 (primary ocular
toxoplasmosis), the evolution of this rise in the serum level
of specific IgG paralleled the local course (Fig. 1e). In
group 2 (secondary ocular toxoplasmosis), the serum levels
of specific IgG did not change during the entire monitoring
period (100 days; Fig. 1f).
The activation of a humoral immune response was also
reflected in the levels of total IgG. In group 1 (primary
ocular toxoplasmosis), the level of total IgG had risen after
3 weeks by less than 2-fold in the serum, by 3-fold in the
aqueous humor of the uninfected partner eye, and by more
than 20-fold in the aqueous humor of the inoculated eye
(Fig. 2a). In group 2 (secondary ocular toxoplasmosis), the
level of total IgG did not change either in the serum or in
the aqueous humor of the uninfected partner eye. But in the
inoculated eye, the local level rose 8- to 10-fold after
10 days (Fig. 2b). This increase may be accounted for by
local specific IgG production and by an uveovascular
barrier breakdown.
In group 1 (primary ocular toxoplasmosis), the antibody
ratio C was indicative of local IgG production (≥3) in
single instances from day 5 to day 42 in the inoculated eye,
and from days 15 to 42 in the uninfected partner eye
(Fig. 3a). In group 2 (secondary ocular toxoplasmosis), the
antibody ratio C values were significantly lower. For the
inoculated eye, they were indicative of local IgG produc-
tion (≥3) from day 21 to day 72; whereas for the uninfected
partner eye, they were at no time indicative (Fig. 3b).
After systemic (subcutaneous) infection of infection-
naïve rabbits (n=12; group 2 prior to intraocular infection),
the levels of both specific and total IgG rose significantly
(p<0.05) and in parallel from day 15 in the serum and from
day 21 in the aqueous humour (Fig. 4a,b), which is 5 or
more days later than after ocular infection. The level of
total IgG in the serum rose 2-fold, which corresponds to the
rise observed after the ocular infection of naïve animals
(primary ocular toxoplasmosis (group 1)) at a later stage.
The level of total IgG in the aqueous humor of these
clinically uninfected eyes (right and left) rose 3-fold
(Fig. 4b), which indicates a moderate compromise of the
uveovascular barrier. By 2 months, the situation had
normalized (Fig. 4b). In the absence of clinically detectable
lesions, the antibody ratio C became indicative (≥3) at least
once between days 21 and 60 in 9 eyes of the 6 surviving
rabbits and remained negative throughout in the 6 eyes of
the 3 remaining rabbits (Fig. 4c). Correction for breakdown
of the uveovascular barrier would have increased the
number of indicative antibody ratios.
Discussion
The present study was undertaken with a view to
improving our understanding of the dynamics of the
humoral immune response in ocular toxoplasmosis, and to
shedding further light on the factors contributing to its
sensitivity and specificity. Regarding the underlying
principles of the humoral immune response, the clinically
most interesting findings of our study are the following:
– The existence of a diagnostic window embracing
infection, clinical symptoms, and the local immune
response, which is more pronounced in secondary
(recurrent) than in primary ocular toxoplasmosis
(Fig. 1a,b)
– The antibody ratio C values suggest the existence of
plasma-cell homing after 15 days in the uninfected
partner eye of rabbits with primary ocular toxoplas-
mosis (Fig. 3a), but not in those with secondary ocular
toxoplasmosis (Fig. 3b). It should be borne in mind,
however, that although a measurable rise in specific
IgG production was discernible, the increase was not
significant
– An increase in the serum level of specific IgG was
detected in infection-naïve rabbits (primary ocular
toxoplasmosis; Fig. 1e), but not in infection-immu-
nized animals (secondary ocular toxoplasmosis;
Fig. 1f), which is in accordance with clinical
experience
– A breakdown of the uveovascular barrier, with a
relative increase in the level of total IgG, was observed
3Fig. 1 Median, minimal, and maximal values (expressed in
International Unit equivalents [IU] of Toxoplasma-specific IgG) are
presented. Values near the detection limit of the anti-Toxoplasma
IgG ELISA test system were arbitrarily set at 0.1 IU to permit their
graphical representation. a Activation of Toxoplasma-specific IgG
production in the aqueous humor of the inoculated eye of infection-
naïve rabbits with primary ocular toxoplasmosis (group 1; n=10).
Specific IgG reached detectable levels in the inoculated eyes
between 5 and 15 days after inoculation, attaining statistical
significance from day 15 onwards. b Activation of Toxoplasma-
specific IgG production in the aqueous humor of the inoculated eye
of infection-immunized rabbits with secondary ocular toxoplasmosis
(group 2; n=9). Compared with the base-line level, the increase in
specific IgG attained statistical significance from day 5 onwards. c
Activation of Toxoplasma-specific IgG production in the aqueous
humor of the uninfected partner eye of infection-naïve rabbits with
primary ocular toxoplasmosis (group 1; n=10). Specific IgG levels
in the uninoculated eyes lay regularly below those of inoculated
eyes, sporadically reaching detectable levels between 5 and 21 days
after inoculation and attaining statistical significance from day 49
onward. d Activation of Toxoplasma-specific IgG production in the
aqueous humor of the uninfected partner eye of infection-
immunized rabbits with secondary ocular toxoplasmosis (group 2;
n=9). Compared with the base-line level, the increase in specific IgG
never attained statistical significance. e Activation of Toxoplasma-
specific IgG production in the serum of infection-naïve rabbits with
primary ocular toxoplasmosis (group 1; n=10). Compared with the
base-line level, the increase in specific IgG attained statistical
significance from day 10 onwards. Typically for naïve rabbits, low
levels of naturally occurring unspecific serum antibodies against
Toxoplasma gondii are detectable. f Activation of Toxoplasma-
specific IgG production in the serum of infection-immunized rabbits
with secondary ocular toxoplasmosis (group 2; n=9). Compared
with the base-line level, the level of specific IgG did not change
significantly during the monitoring period
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in primary, but not in secondary ocular toxoplasmosis
(Fig. 2a,b)
– In systemic toxoplasmosis, there was evidence of an
unremarkable, site-specific increase in specific and
total IgG (Fig. 4a,b), which resulted in the sporadic
attainment of indicative antibody ratios (Fig. 4c)
In atypical cases of ocular toxoplasmosis, a laboratory
confirmation of the suspected clinical diagnosis is
recommended [3, 4, 10, 20, 22, 28, 29, 40–42, 44]. This
is based on the detection of Toxoplasma gondiiDNAwithin
either the aqueous humor or, preferably, the vitreous [1, 2,
7, 16, 52], and of local specific antibody production [20].
However, our poor understanding of the dynamics of local
antibody production and the absence of a single,
sufficiently sensitive and specific laboratory test [52]
have not encouraged the broad clinical acceptance of a
combined serum and aqueous humor antibody analysis in
suspected cases of ocular toxoplasmosis. On the other
hand, the usefulness of performing serological tests in
pregnant women and in newborn infants to establish the
existence of a congenitally transferred infection [6], and the
recognition of a compartmentalized humoral immune
response in ocular disease [32], are generally accepted.
Although it could be argued that our experimental rabbit
model does not closely resemble the human situation
quantitatively, it is nevertheless useful in testing some of
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Fig. 2 a Median total IgG
levels in infection-naïve rabbits
with primary ocular toxoplas-
mosis (group 1; n=10). Break-
down of the uveovascular
barrier is indicated by a more
than 20-fold increase in the level
of total IgG in the aqueous
humor of the infected (left) eye
and by up to a 3-fold one in the
uninfected (right) eye. b Median
total IgG levels in infection-
immunized rabbits with second-
ary ocular toxoplasmosis (group
2; n=9). Breakdown of the
uveovascular barrier is indicated
by up to a 10-fold increase in
the level of total IgG in the
aqueous humor of the infected
(left) eye and by a 2-fold one in
the uninvolved (right) eye
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the principles governing the humoral immune response. In
a previous study comparing outbred and inbred rabbits,
antigen stimulation was reported to increase oxidative
stress, which provoked a compensatory and adaptive up-
regulation of superoxide dismutase for up to 30 days. Both
responses were more pronounced in the inbred than in the
outbred rabbits [46]. The 30-day time course corresponds
with the establishment of a systemic humoral immune
response, as shown in our model and by Langford et al.
[34]. However, great caution must be exercised in drawing
quantitative conclusions, since many unconsidered factors,
such as homozygosity, may interfere with the quantitative
immune response. Tanchev et al. have demonstrated that a
simultaneous immunomodulation may elicit different an-
tibody responses [49]. Such a situation could arise from a
clinically non-evident bacterial or coccidial gastrointestinal
superinfection of the systemically seriously impaired
rabbits after primary Toxoplasma infection and parenteral
antibiotic therapy. The humoral immune response is
obviously paralleled by the cellular one, which is
manifested 14 days after subretinal xenogenic cell
transplantation [15].
Obviously, the intraocular transvitreal route of infection
does not correspond to the natural one. This may be the
weakest aspect of our model, since the route of infection
has a substantial impact not only on the establishment of
the cellular immune response, but also on the quantitative
humoral one [24]. Nevertheless, there is no evidence that
the route of infection interferes with the principal
observations of our study, such as the time course of the
immune response or the response of the partner eye. Hence,
Fig. 3 a Goldmann–Witmer
antibody coefficients (antibody
ratio C) for the infected (left)
and the uninvolved partner
(right) eyes of infection-naïve
rabbits with primary ocular
toxoplasmosis (group 1; n=10).
Median values are represented
together with the standard errors
(bars). Note that diagnostically
indicative values (≥3) are
achieved between days 5 and 42
for the infected eye and spo-
radically between days 15 and
42 for the uninfected partner
eye. b Goldmann–Witmer anti-
body coefficients (antibody ratio
C) for the infected (left) and the
uninvolved partner (right) eyes
of infection-immunized rabbits
with secondary ocular toxoplas-
mosis (group 2; n=9). Median
values are represented together
with the standard errors (bars).
Note that diagnostically indica-
tive values (≥3) are achieved
between days 21 and 72 for the
infected eye, but at no time for
the uninfected partner eye
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Fig. 4 a Activation of Toxo-
plasma-specific IgG production
in the aqueous humor and serum
of naïve rabbits after their sys-
temic infection with Toxoplasma
gondii (n=12). Compared with
the base-line level, the increase
in specific IgG attained statisti-
cal significance from day 15
onward in the serum and from
day 21 onward in the aqueous
humor. Median values (ex-
pressed in IU of Toxoplasma-
specific IgG) are presented.
Values near the detection limit
of the anti-Toxoplasma IgG
ELISA test system were arbi-
trarily set at 0.1 to permit their
graphical representation. b Me-
dian total IgG levels in naïve
rabbits after their systemic in-
fection with Toxoplasma gondii
(n=12). Moderate impairment of
the uveovascular barrier is in-
dicated by up to a 3-fold
increase in the level of total IgG
in the aqueous humor of each
eye, compared with only a 2-
fold one in the serum, which
attained statistical significance
(relative to the base-line level)
on day 21. This finding reflects
not only the activation of plasma
cells, but probably also the im-
pact of frequent anterior-cham-
ber punctures. The situation
normalized after 2 months.
c Goldmann–Witmer antibody
coefficients (antibody ratio C)
for both eyes in naïve rabbits
after their systemic infection
with Toxoplasmosis gondii
(n=12). Median values are re-
presented together with the
standard errors (bars). Signifi-
cant increases (p<0.05) and
diagnostically indicative values
(≥3) are achieved between
days 21 and 60 for single eyes in
the absence of clinically detect-
able lesions. Correction for
uveovascular barrier damage
would have yielded even higher
values
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we are confident that our results will be helpful in
understanding and interpreting clinical laboratory data.
One other critical issue of our study relates to the
frequency of anterior-chamber puncturing. Whether these
interventions underlie the site-specific relative increase in
total aqueous humor IgG above the serum level is open to
discussion (Fig. 4b), since they do not account for the
indicative antibody ratio values observed in more than one-
third of the eyes in the absence of clinically manifest
chorioretinal lesions (Fig. 4c). Also, the cause of the high
inter-individual range of the results cannot be obviously
explained. But they could reflect the relatively low
concentrations of total and specific IgG within the aqueous
humor (compared with those in the serum). These hover
around the lower cut-off detection level for the ELISA test
system. Serum samples, on the other hand, must be diluted.
Despite the limitations of our rabbit model, a more
appropriate alternative has not been described to date [9].
A comparison of our results with existing clinical
laboratory findings reveals several common features:
apart from confirming a humoral infection-associated
immunity to Toxoplasma gondii, a serum antibody analysis
does not otherwise contribute to the diagnosis [20, 25]. If
clinically indicated, laboratory testing is useful only if it
involves a parallel analysis of the humoral immune
response in both the aqueous humor and the serum [10,
29]. But even a combined analysis will not reveal the
expected information if the samples are withdrawn too
early [20], a clinical experience that is also supported by
the present findings.
Local antibody production is deemed to be underway if
the antibody ratio C lies above 3 [10, 23, 29, 30], and it still
represents the hallmark for a laboratory confirmation of
ocular toxoplasmosis. Depending on the case selection
criteria, the sensitivity of this index as a diagnostic tool lies
between 60 and 85% [3, 4, 7, 10, 13, 20, 22, 29, 42, 52],
with a specificity approaching 90% in persons of European
or North American origin if combined with other serolog-
ical analyses, as reported by Villard et al. [52]. Referring to
the sensitivity of antibody ratio C, it has to be kept in mind
that cut-off values may differ between single studies. And,
surprisingly, a generally accepted formulation for determi-
nation of antibody ratio C values has also not been agreed
on. In the above-mentioned study by Villard, for example,
the integrity of the blood–aqueous barrier was assessed not
by comparing anti-Toxoplasma-specific antibodies with the
total IgG fraction, as is usual, but with antibodies against
the Mumps virus. These antibodies may attain a serum
prevalence of 100% in a healthy population without
inducing chorioretinitis. Hence, their presence in the
aqueous humor reflects a passive transudation from the
serum through an impaired blood–retina barrier. This
modification was first suggested by Turunen et al. [50], and
the sensitivity and specificity thereby achieved are possibly
better than when the comparison is based on the total IgG
level. However, we have been unable to identify a rabbit
ELISA kit of corresponding sensitivity and specificity.
Nevertheless, a confirmation of antibody production within
the eye indicates that the site of inflammatory activity may
be localized to this organ, which would be expected for the
congenitally-contracted disease. In patients with an ac-
quired form of the disease, clinical manifestations may be
restricted to the eye even if the infection is systemic [31,
32, 39]. This aspect has not been addressed with this
model, although the positive local antibody indices found
even in systemic disease without evident ocular involve-
ment, together with clinical experience, argue against the
assumption of an absolute compartment-specific humoral
immune response [32].
Several aspects relating to the diagnosis of ocular
toxoplasmosis are still under debate. One of these concerns
the time elapsing between the onset of clinical symptoms
and the induction of local antibody production. In two-
thirds of patients who register negative for specific
antibody production at the first clinical presentation,
evidence of induction is revealed at a later stage [20].
This finding is consistent with earlier results of our own
pertaining to the experimental rabbit model of ocular
toxoplasmosis [19]. These revealed that local antibody
production did not begin until 2 weeks after inoculation
and 10 days after a marked infiltration of the vitreous.
Humoral and/or cellular immunotolerance phenomena
could conceivably account for the failure to detect specific
antibodies within the aqueous humor [54]. Numerous other
and as yet unidentified factors may be relevant, including
the virulence of the parasite, its route of acquisition and
immunogenetic influences [17]. These might contribute to
intraocular infection-associated inflammatory processes in
general [14, 47] and to ocular toxoplasmosis in particular
[12, 51]. However, these possibilities have not been
systematically investigated. Another debatable issue is
the persistence of local antibody production after the
cessation of disease activity, and the possible presence of
specific antibodies in uninvolved eyes. Our own data
(Fig. 1a–f) as well as clinical observations by other
investigators [13] support these contentions.
Although we are well aware that our experimental rabbit
model of ocular toxoplasmosis does not closely resemble
the human ocular disease, and that the dynamics of the
specific humoral immune response may differ from the
human situation, our data nevertheless afford an insight
into some of the clinically suspected or even accepted, but
hitherto not experimentally demonstrated, aspects of the
local humoral immune response in ocular toxoplasmosis.
Thus, they contribute to our understanding of the disease
and support our diagnostic attitude towards its laboratory
confirmation.
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